ClinicalTrials.govpublic full text
Fluvoxamine for Adults With Mild to Moderate COVID-19
severe acute respiratory syndrome coronavirus 2, coronavirus infection, mild to moderate covid-19, fluvoxamine, sars-cov-2 treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858210
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.